NEW YORK, Aug. 19, 2021 /PRNewswire/ -- The Europe urethral bulking systems market was valued US$ 21.2 Mn in 2020, and is expected to accelerate at a decent CAGR of approximately 6% over the forecast ...
Injection of bulking agents into the urethral sphincter is the standard minimally invasive procedure used to treat stress urinary incontinence (SUI). Mayer et al. examined the safety and effectiveness ...
We have moved interventional procedures guidance 138 to become HealthTech guidance 86. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment ...
December 4, 2006 -- The US Food and Drug Administration (FDA) has approved a urethral bulking agent for the treatment of stress urinary incontinence in women; a propylene mesh urethral sling for the ...
Bulkamid® Urethral Bulking System is indicated for urethral injection for the treatment of stress urinary incontinence (SUI) due to intrinsic sphincter deficiency (ISD) in adult women who have SUI or ...
An estimated 15 million women in the U.S. deal with stress urinary incontinence, an accidental leak of urine after pressure on the bladder from movement, a cough or a sneeze. A new procedure being ...
Stress urinary incontinence in men is usually a result of intrinsic sphincter deficiency following prostate cancer surgery. Active conservative management with fluid restriction, medication management ...
IRVINE, Calif.--(BUSINESS WIRE)-- Axonics Modulation Technologies, Inc. (Nasdaq: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results